In this study, we investigated the effect of a novel retinobenzoic acid, 4-[3,5-bis (trimethylsilyl) benzamido] benzoic acid (TAC-101), on the growth of 4 human pancreatic-cancer cell lines; BxPC-3, MIAPaCa-2, CFPAC-1 and AsPC-1. TAC-101 significantly inhibited the proliferation of BxPC-3 and MIA-Pa
Induction of G2/M phase arrest and apoptosis by a novel indoloquinoline derivative, IQDMA, in K562 cells
โ Scribed by Yi-Hsiung Lin; Sheng-Huei Yang; Ching-Ming Chien; Xiu-Wei Hu; Ying-Hui Huang; Chih-Ming Lu; Yeh-Long Chen; Shinne-Ren Lin
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 265 KB
- Volume
- 67
- Category
- Article
- ISSN
- 0272-4391
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract Bisphosphonates (BPs) are widely used in the treatment of osteolytic bone disease associated with multiple myeloma, and have been demonstrated to exert antitumor effects both __in vitro__ and __in vivo__. However, the precise molecular mechanisms involved in the direct antitumor effects
Bin1 is a novel protein that specifically binds Myc and inhibits, at least in part, Myc transactivation. Bin1 seems to play a role in cell cycle control, acting as a tumor suppressor gene. Since MYC family genes play a regulatory role in the proliferation, differentiation, and apoptosis of the nervo